104 related articles for article (PubMed ID: 21737664)
61. DNA-PKcs expression in esophageal cancer as a predictor for chemoradiation therapeutic sensitivity.
Noguchi T; Shibata T; Fumoto S; Uchida Y; Mueller W; Takeno S
Ann Surg Oncol; 2002 Dec; 9(10):1017-22. PubMed ID: 12464596
[TBL] [Abstract][Full Text] [Related]
62. Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1α in esophageal cancer cells.
Zhang GJ; Gao R; Wang JS; Fu JK; Zhang MX; Jin X
Dis Esophagus; 2011 Sep; 24(7):481-8. PubMed ID: 21309917
[TBL] [Abstract][Full Text] [Related]
63. Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer.
Novell A; Martínez-Alonso M; Mira M; Tarragona J; Salud A; Matias-Guiu X
Virchows Arch; 2014 Jun; 464(6):645-54. PubMed ID: 24711168
[TBL] [Abstract][Full Text] [Related]
64. HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer.
Huang YJ; Chen YT; Huang CM; Kuo SH; Liao YY; Jhang WY; Wang SH; Ke CC; Huang YH; Cheng CM; Huang MY; Chuang CH
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011045
[TBL] [Abstract][Full Text] [Related]
65. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.
Igbo BT; Jentsch C; Linge A; Plesca I; Kuzay Y; Löck S; Kumaravadivel MS; Doms S; Stolz-Kieslich L; Pollack D; Brückmann S; Tittlbach H; Weitz J; Aust D; Apolle R; Schmitz M; Troost EGC
Strahlenther Onkol; 2024 Jul; 200(7):595-604. PubMed ID: 38727811
[TBL] [Abstract][Full Text] [Related]
66. Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review.
Peerlings J; Van De Voorde L; Mitea C; Larue R; Yaromina A; Sandeleanu S; Spiegelberg L; Dubois L; Lambin P; Mottaghy FM
Methods; 2017 Nov; 130():51-62. PubMed ID: 28705470
[TBL] [Abstract][Full Text] [Related]
67. Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer.
Havelund BM; Spindler KL; Ploen J; Andersen RF; Jakobsen A
Oncol Lett; 2012 Nov; 4(5):1056-1060. PubMed ID: 23162650
[TBL] [Abstract][Full Text] [Related]
68. [Liquid Biopsy in Multimodal Treatment of Esophageal Carcinoma].
Shimada H; Yajima S; Oshima Y; Nanami T; Suzuki T; Otsuka S
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1335-7. PubMed ID: 26602390
[TBL] [Abstract][Full Text] [Related]
69. Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinoma.
Sobajima J; Kumamoto K; Haga N; Tamaru J; Takahashi T; Miyazaki T; Ishida H
Oncol Lett; 2012 Feb; 3(2):287-292. PubMed ID: 22740896
[TBL] [Abstract][Full Text] [Related]
70. Retraction notice to "Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway" [Life Sci. 257 (2020) 118104].
Wang Y; Xie Z; Lu H
Life Sci; 2022 Nov; 308():120813. PubMed ID: 35945078
[No Abstract] [Full Text] [Related]
71. Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
Cowman SJ; Fuja DG; Liu XD; Tidwell RSS; Kandula N; Sirohi D; Agarwal AM; Emerson LL; Tripp SR; Mohlman JS; Stonhill M; Garcia G; Conley CJ; Olalde AA; Sargis T; Ramirez-Torres A; Karam JA; Wood CG; Sircar K; Tamboli P; Boucher K; Maughan B; Spike BT; Ho TH; Agarwal N; Jonasch E; Koh MY
Clin Cancer Res; 2021 Jun; 27(11):3265. PubMed ID: 34074655
[No Abstract] [Full Text] [Related]
72. HIF-1α Cardioprotection in COVID-19 Patients.
Wang BJ; Vadakke-Madathil S; Croft LB; Brody RI; Chaudhry HW
JACC Basic Transl Sci; 2022 Jan; 7(1):67-69. PubMed ID: 35097242
[No Abstract] [Full Text] [Related]
73. Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma.
Igbo BT; Linge A; Frosch S; Suckert T; Stolz-Kieslich L; Löck S; Kumaravadivel MS; Welsch T; Weitz J; Sommer U; Aust D; Troost EGC
Clin Transl Radiat Oncol; 2022 Sep; 36():106-112. PubMed ID: 35993091
[TBL] [Abstract][Full Text] [Related]
74. Prognostic value of HIF-1α in digestive system malignancies: evidence from a systematic review and meta-analysis.
Arjmand MH; Moradi A; Rahimi HR; Es-Haghi A; Akbari A; Hadipanah MR; Afshar J; Mehrad-Majd H
Gastroenterol Hepatol Bed Bench; 2022; 15(2):108-119. PubMed ID: 35845307
[TBL] [Abstract][Full Text] [Related]
75. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
[TBL] [Abstract][Full Text] [Related]
76. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.
Macedo-Silva C; Miranda-Gonçalves V; Lameirinhas A; Lencart J; Pereira A; Lobo J; Guimarães R; Martins AT; Henrique R; Bravo I; Jerónimo C
Cell Death Dis; 2020 Dec; 11(12):1068. PubMed ID: 33318475
[TBL] [Abstract][Full Text] [Related]
77. Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells.
Jin X; Gong L; Peng Y; Li L; Liu G
Aging (Albany NY); 2020 Dec; 13(1):364-375. PubMed ID: 33290263
[TBL] [Abstract][Full Text] [Related]
78. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance.
Macedo-Silva C; Miranda-Gonçalves V; Henrique R; Jerónimo C; Bravo I
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31739546
[TBL] [Abstract][Full Text] [Related]
79. The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism.
Lv X; Li J; Zhang C; Hu T; Li S; He S; Yan H; Tan Y; Lei M; Wen M; Zuo J
Genes Dis; 2017 Mar; 4(1):19-24. PubMed ID: 30258904
[TBL] [Abstract][Full Text] [Related]
80. Adipose tissue dysfunction and its effects on tumor metabolism.
Diedrich J; Gusky HC; Podgorski I
Horm Mol Biol Clin Investig; 2015 Jan; 21(1):17-41. PubMed ID: 25781550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
